IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

International Biotechnology Trust PLC

Q2 2022 Holdings

Filed 2022-08-16 | 78 holdings | $9.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Amicus Therapeutics Inc C(FOLD)COM03152W109$94.6K1,0171.0%
Gamida CellSHSM47364100$107.0K1871.1%
Ideaya Biosciences Inc Co(IDYA)COM45166A102$109.0K1,5011.1%
Chemocentryx Inc COM STK(CCXIEUR)COM16383L106$121.1K3,0001.3%
Galapagos(GLPG)SPONSORED ADR36315X101$123.3K6,8761.3%
Novavax Inc(NVAX)COM670002401$132.5K6,8141.4%
Mirati Therapeutics Inc C(MRTXEUR)COM60468T105$136.0K9,1311.4%
Gilead Sciences Inc Commo(GILD)COM375558103$145.8K9,0121.5%
Fate Therapeutics Inc COM(FATE)COM31189P102$158.0K3,9171.6%
Ultragenyx Pharmaceutical(RARE)COM90400D108$161.1K9,6101.7%
Fulcrum Therapeutics Inc(FULC)COM359616109$193.7K9492.0%
Harmony Biosciences Holdi(HRMY)COM413197104$221.5K10,7942.3%
Neurocrine Biosciences in(NBIX)COM64125C109$236.0K23,0082.5%
Incyte Corp Inc COM(INCY)COM45337C102$238.0K18,0812.5%
Caribou Biosciences Inc C(CRBU)COM142038108$254.7K1,3782.7%
Iovance Biotherapeutics I(IOVA)COM462260100$273.0K3,0112.8%
Vera Therapeutics(VERA)CL A92337R101$281.1K3,8252.9%
Horizon Therapeutics PLCSHSG4617B105$287.0K22,9153.0%
Supernus Pharmaceuticals(SUPN)COM868459108$297.5K8,6043.1%
Chinook Therapeutics Inc(290A)COM16961L106$340.4K5,9473.6%
Exelixis Inc COM(EXEL)COM30161Q104$350.0K7,2903.7%
Travere Therapeutics Inc(TVTX)COM89422G107$380.0K9,2154.0%
Kalvista Pharmaceuticals(KALV)COM483497103$383.2K3,7604.0%
Uniqure N.V. COM Eur0.05(QURE)SHSN90064101$446.5K8,3184.7%
I-Mab Sponsored ADS(NBP)SPONSORED ADS44975P103$553.0K6,2325.8%
Dyne Therapeutics Inc COM(DYN)COM26818M108$562.6K3,8655.9%
Aurinia Pharmaceuticals I(AUPH)COM05156V102$573.5K5,7586.0%
Concert Pharmaceuticals I(CNCEEUR)COM206022105$620.0K2,6106.5%
PreviousPage 2 of 2